Discover
LEXX
Lexaria Bioscience Corp.
0.57
2 x 0.39
2 x 0.74
bid
ask
+
0.01
2.14%
2 @ 05:05 AM
0.56 -0.01 (1.22%)
| Ytd | -7.29% | |
| 1y | -32.71% |
0.56
day range
0.58
0.46
52 week range
1.55
| Open | 0.57 | Prev Close | 0.56 | Low | 0.56 | High | 0.58 | Mkt Cap | 14.18M |
| Vol | 14.85K | Avg Vol | 145.04K | EPS | -0.47 | P/E | N/A | Forward P/E | -5.64 |
| Beta | 1.06 | Short Ratio | 2.34 | Inst. Own | 6.08% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-14 | 50-d Avg | 0.65 | 200-d Avg | 0.83 | 1yr Est | 10.00 |
| Income Statement | |||
| Total Revenue | 20.00K | ||
| Revenues (USD) | 20.00K | ||
| Gross Profit | 20.00K | ||
| Operating Expenses | 1.47M | ||
| Research and Development Expense | 475.39K | ||
| Selling, General and Administrative Expense | 996.52K | ||
| Operating Income | -1.45M | ||
| Income Tax Expense | 2.60K | ||
| Net Income | -1.45M | ||
| Net Income Common Stock | -1.45M | ||
| Net Income Common Stock (USD) | -1.45M | ||
| Consolidated Income | -1.45M | ||
| Net Income to Non-Controlling Interests | -2.75K | ||
| Earnings per Basic Share | -0.06 | ||
| Earnings per Basic Share (USD) | -0.06 | ||
| Earnings per Diluted Share | -0.06 | ||
| Earning Before Interest & Taxes (EBIT) | -1.45M | ||
| Earning Before Interest & Taxes (USD) | -1.45M | ||
| Weighted Average Shares | 24.44M | ||
| Weighted Average Shares Diluted | 24.44M | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.13M | ||
| Cash and Equivalents (USD) | 5.13M | ||
| Investments | 141.27K | ||
| Investments Current | 141.27K | ||
| Trade and Non-Trade Receivables | 106.04K | ||
| Current Assets | 5.77M | ||
| Property, Plant & Equipment Net | 334.95K | ||
| Total Assets | 6.49M | ||
| Debt Current | 32.06K | ||
| Total Debt | 94.39K | ||
| Current Liabilities | 214.67K | ||
| Debt Non-Current | 62.33K | ||
| Total Liabilities | 277.00K | ||
| Accumulated Retained Earnings (Deficit) | -66.51M | ||
| Accumulated Other Comprehensive Income | -55.44K | ||
| Shareholders Equity | 6.60M | ||
| Shareholders Equity (USD) | 6.60M | ||
| Assets Non-Current | 717.02K | ||
| Total Debt (USD) | 94.39K | ||
| Goodwill and Intangible Assets | 318.06K | ||
| Liabilities Non-Current | 62.33K | ||
| Trade and Non-Trade Payables | 182.61K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 28.37K | ||
| Net Cash Flow from Financing | 3.04M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 846.91K | ||
| Capital Expenditure | -40.82K | ||
| Issuance (Purchase) of Equity Shares | 3.04M | ||
| Net Cash Flow from Investing | -53.91K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 2.00K | ||
| Net Cash Flow from Operations | -2.16M | ||
| Effect of Exchange Rate Changes on Cash | 20.64K | ||
| Share Based Compensation | 74.90K | ||